Rishi Sunak is renewing calls for a 'vital' national prostate cancer-screening programme as he prepares to attend a testing ...

This approval is based on final data from the PRIMA trial, where the MyChoice CDx Test determined homologous recombination deficiency (HRD) status and was used to stratify advanced ovarian cancer ...

A writer who assumed mammograms were someone else's problem now has a standing date with the machine. In the Los Angeles ...

A new international study has found that combining two cancer medicines may significantly slow the growth of a dangerous form of prostate cancer in some men. The research was led by scientists at ...

Jacob Johnson learned that he was a carrier for the BRCA2 gene in 2013 after testing was recommended due to a strong history of breast cancer among relatives — including his mother, several aunts, a ...

Nearly 10 years after Chrissy Hofbeck first competed on Survivor during Season 35, where she finished as the runner-up, the mom of four is back in Survivor 50. With many fans feeling like Hofbeck ...

The FDA approved this combination tablet in the same population late last year based on the AMPLITUDE study data.

A clustered family history of breast, ovarian, and colon cancers appropriately triggered germline testing, with BRCA1 mutation status informing individualized risk stratification and counseling.

Four years ago, María, Adriana, and Paula López Fontanals received one of those life-changing pieces of news: it would change their bodies, their relationships with motherhood, with their daughters, ...

An estimated 170,000 Australians were diagnosed with cancer in 2025. Many people know the causes of cancer are partly genetic. But how do your genes, which contribute so much of what makes you you, ...